| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 112 |
| 1 | CARBOPLATIN | 67 |
| 2 | NIVOLUMAB | 66 |
| 3 | PACLITAXEL | 50 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 50 |
| 5 | IPILIMUMAB | 40 |
| 6 | HYDROCORTISONE | 35 |
| 7 | HYDROCORTISONE ACETATE | 33 |
| 8 | ANTI ITCH | 32 |
| 9 | ANTI-ITCH | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METYRAPONE | 12 | 0.0120 |
| 1 | PEGFILGRASTIM-JMDB | 4 | 0.0088 |
| 2 | TEBENTAFUSP | 4 | 0.0066 |
| 3 | PASIREOTIDE | 12 | 0.0053 |
| 4 | BEVACIZUMAB-ADCD | 1 | 0.0049 |
| 5 | COSYNTROPIN | 1 | 0.0045 |
| 6 | OSILODROSTAT | 10 | 0.0045 |
| 7 | FOSNETUPITANT AND PALONOSETRON | 5 | 0.0042 |
| 8 | NETUPITANT AND PALONOSETRON | 5 | 0.0042 |
| 9 | CHORIONIC GONADOTROPIN | 2 | 0.0036 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 12 | 0.0120 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 4 | 0.0066 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 184 | 0.0019 |
| 3 | Somatostatin Analog [EPC] | 11 | 0.0016 |
| 4 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 5 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 6 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 7 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 43 | 0.0009 |
| 9 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |